New approach for local delivery of rapamycin by bioadhesive PLGA-carbopol nanoparticles

Drug Delivery

Volumn 16, Issue 1, 2009, Pages 15-23

  Zou, Weiwei ^a   Cao, Guangqing ^b   Xi, Yanwei ^a   Zhang, Na ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Vascular restenosis

Indexed keywords

CARBOPOL 940; NANOPARTICLE; POLYGLACTIN; RAPAMYCIN; ACRYLIC ACID RESIN; DRUG CARRIER; EXCIPIENT; IMMUNOSUPPRESSIVE AGENT; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ARTERY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG RETENTION; DRUG STABILITY; DRUG UPTAKE; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; ZETA POTENTIAL; ADHESION; ANIMAL; CELL SURVIVAL; CHEMISTRY; DOG; DRUG EFFECT; RESTENOSIS;

ACRYLIC RESINS; ADHESIVENESS; ANIMALS; CELL SURVIVAL; CORONARY RESTENOSIS; DOGS; DRUG CARRIERS; DRUG STABILITY; EXCIPIENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LACTIC ACID; NANOPARTICLES; PARTICLE SIZE; POLYGLYCOLIC ACID; SIROLIMUS;

EID: 68749093382     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540802481307     Document Type: Article

References (33)

1. Braun-Dullaeus RC, Mann MJ, Seay U, Zhang L, von Der Leyen HE, Morris RE, Dzau VJ (2001). Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin. Arterioscler. Thromb. Vasc. Biol. 21, 1152-1158.
2. Cui F, Qian F, Yin C (2006). Preparation and characterization of mucoadhesive polymer-coated nanoparticles. Int. J. Pharm. 316, 154-161.
3. Derakhshandeh K, Erfan M, Dadashzadeh S (2007). Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: Factorial design, characterization and release kinetics. Eur. J. Pharm. Biopharm. 66, 34-41.
4. Dimitrova B, Ivanov IB, Nakache E (1988). Mass transport effects on the stability of emulsion: Emulsion films with acetic acid and acetone diffusing across the interface. J. Dispersion Sci. Technol. 9, 321-341.
5. Dong Y, Feng SS (2005). Poly(d,l-lactide-co-glycolide)/ montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials 26, 6068-6076.
6. Feng S, Huang G (2001). Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. J. Contr. Rel. 71 , 53-69.
7. Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S (1989). Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm. 55, R1-R4.
8. Gallo R, Padurean A, Jayaraman T, Marx S, Roque M, Adelman S, Chesebro J, Fallon J, Fuster V, Marks A, Badimon JJ (1999). Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation 99, 2164-2170.
9. Geresh S, Gdalevsky GY, Gilboa I, Voorspoels J, Remon JP, Kost J (2004). Bioadhesive grafted starch copolymers as platforms for peroral drug delivery: A study of theophylline release. J. Contr. Rel. 94, 391-399.
10. Grabovac V, Guggi D, Bernkop-Schnürch A (2005). Comparison of the mucoadhesive properties of various polymers. Adv. Drug Deliv. Rev. 57, 1713-1723.
11. Kim DH, Martin DC (2006). Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. Biomaterials 27, 3031-3037.
12. Kockisch S, Rees GD, Young SA, Tsibouklis J, Smart JD (2001). A direct- staining method to evaluate the mucoadhesion of polymers from aqueous dispersion. J. Contr. Rel. 77, 1-6.
13. Labhasetwar V, Song C, Levy RJ (1997). Nanoparticle drug delivery system for restenosis. Adv. Drug Deliv. Rev. 24, 63-85.
14. Mei L, Sun H, Jin X, Zhu D, Sun R, Zhang M, Song C (2007). Modified paclitaxel-loaded nanoparticles for inhibition of hyperplasia in a rabbit arterial balloon injury model. Pharm. Res. 24, 955-962.
15. Mitchel JF, Fram DB, Palme DF, Foster R, Hirst JA, Azrin MA, Bow LM, Eldin AM, Waters DD, McKay RG (1995). Enhanced intracoronary thrombolysis with urokinase using a novel, local drug delivery system. In vitro, in vivo, and clinical studies. Circulation 91, 785-793.
16. Mortazavi SA (1995). An in vitro assessment of mucus/ mucoadhesive interactions. Int. J. Pharm. 124, 173-182.
17. Murakami H, Kobayashi M, Takeuchi H, Kawashima Y (2000). Further application of a modified spontaneous emulsification solvent diffusion method to various types of PLGA PLA polymers for preparation of nanoparticles. Powder Technol. 107, 137-143.
18. Oster CG, Wittmar M, Bakowsky U, Kissel T (2006). DNA nano-carriers from biodegradable cationic branched polyesters are formed by a modified solvent displacement method. J. Contr. Rel. 111, 371-381.
19. Poon M, Marx SO, Gallo R, Badimon JJ, Taubman MB, Marks AR (1996). Rapamycin inhibits vascular smooth muscle cell migration. J. Clin. Invest. 98, 2277-2283.
20. Quintanar-Guerrero D, Allémann E, Doelker E, Fessi H (1997). A mechanistic study of the formation of polymer nanoparticles by the emulsification-diffusion technique. Colloid Polym. Sci. 275, 640-647. (Pubitemid 27384865)
21. Ribeiroa HS, Chua B, Ichikawa S, Nakajima M(2008). Preparation of nanodispersions containing £-carotene by solvent displacement method. Food Hydrocolloids 22, 12-17.
22. Sahoo SK, Panyam J, Prabha S, Labhasetwar V (2002). Residual polyvinyl alcohol associated with poly (d,l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J. Contr. Rel. 82, 105-114.
23. Salman HH, Gamazo C, Campanero MA, Irache JM (2005). Salmonellalike bioadhesive nanoparticles. J. Contr. Rel. 106, 1-13.
24. Song C, Labhasetwar V, Cui X, Underwood T, Levy RJ (1998). Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: Results with an acute dog model. J. Contr. Rel. 54, 201-211.
25. Song C, Labhasetwar V, Murphy H, Qu X, Humphrey WR, Shebuski RJ, Levy RJ (1997). Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery. J. Contr. Rel. 43, 197-212.
26. Sternling CV, Scriven LE (1959). Interfacial turbulence: Hydrodynamic instability and the Marangoni effect. AIChE J. 5, 514-523.
27. Takeuchi H, Yamamoto H, Kawashima Y (2001). Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv. Drug Deliv. Rev. 47, 39-54. (Pubitemid 32209231)
28. Vandervoort J, Ludwig A (2002). Biocompatible stabilizers in the preparation of PLGA nanoparticles: A factorial design study. Int. J. Pharm. 238, 77-92.
29. Wessely R, Schömig A, Kastrati A (2006). Sirolimus and Paclitaxel on polymer-based drug-eluting stents: Similar but different. J. Am. Coll. Cardiol. 47, 708-714. (Pubitemid 43243089)
30. Westedt U, Barbu-Tudoran L, Schaper AK, Kalinowski M, Alfke H, Kissel T (2004). Effects of different application parameters on penetration characteristics and arterial vessel wall integrity after local nanoparticle delivery using a porous balloon catheter. Eur. J. Pharm. Biopharm. 58, 161-168.
31. Westedt U, Kalinowski M, Wittmar M, Merdan T, Unger F, Fuchs J, Schäller S, Bakowsky U, Kissel T (2007). Poly(vinyl alcohol)-graftpoly( lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment. J. Contr. Rel. 119 , 41-51.
32. Zambaux MF, Bonneaux F, Gref R, Maincent P, Dellacherie E, Alonso MJ, Labrude P, Vigneron C (1998). Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. J. Contr. Rel. 50, 31-40.
33. Zhao M, Li Z, Wu Y, Tang YR, Wang C, Zhang Z, Peng S (2007). Studies on logP, retention time and QSAR of 2-substituted phenylnitronyl nitroxides as free radical scavengers. Eur. J. Med. Chem. 42, 955-965.